Spruce Biosciences, Inc. (SPRB) Financials

SPRB Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 103.9 million 27.4 million
2023-09-30 113.0 million 27.6 million
2023-06-30 126.0 million 29.4 million
2023-03-31 139.1 million 31.1 million

SPRB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.2 million 1.2 million
2023-09-30 -12.3 million 1.1 million
2023-06-30 2.0 million 1.2 million
2023-03-31 -11.8 million 1.1 million

SPRB Net Income

No data available :(

SPRB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 96.3 million - 1.3 million
2023-09-30 108.0 million - 1.3 million
2023-06-30 120.5 million 2.5 million 1.1 million
2023-03-31 118.6 million 2.9 million 1.2 million

SPRB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 41.0 million
2023-09-30 40.7 million
2023-06-30 40.5 million
2023-03-31 31.9 million

SPRB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 11.1 million 3.0 million -16000
2023-09-30 7000 13.5 million 3.2 million -
2023-06-30 - 13.1 million 3.0 million -
2023-03-31 - 11.7 million 3.5 million -

SPRB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.9 million 16000
2023-09-30 3.1 million 17000
2023-06-30 2.2 million 74000
2023-03-31 2.0 million 77000

SPRB

Price: $0.70

52 week price:
0.68
5.95

Earnings Per Share: -1.24 USD

P/E Ratio: -3.24

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 65629

Market Capitalization: 33.9 million

Links: